| Authors: |
Aguiar-Ibáñez R; Merck Canada Inc, Kirkland, QC, Canada., Goldschmidt D; Analysis Group, Inc, Boston, MA, USA., Zhou ZY; Analysis Group Inc, London, UK., Eales J; Analysis Group Inc, London, UK., Peters S; Centre Hospitalier Universitaire Vaudois (CHUV) Oncology Department, Lausanne, Switzerland., Cardoso F; ABC Global Alliance, Lisbon, Portugal., Ciani O; Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Milan, Italy., Arunachalam A, Haiderali A; Merck & Co., Inc., Rahway, NJ, USA., Roediger A; Merck & Co., Inc., Rahway, NJ, USA., Black CM; Merck & Co., Inc., Rahway, NJ, USA., Martinez E; Merck & Co., Inc., Rahway, NJ, USA., Garrison LP Jr; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA. |
